BR0000011A - Injectable compositions of pre-mixed alatrofloxacin - Google Patents

Injectable compositions of pre-mixed alatrofloxacin

Info

Publication number
BR0000011A
BR0000011A BR0000011-6A BR0000011A BR0000011A BR 0000011 A BR0000011 A BR 0000011A BR 0000011 A BR0000011 A BR 0000011A BR 0000011 A BR0000011 A BR 0000011A
Authority
BR
Brazil
Prior art keywords
alatrofloxacin
mixed
compositions
injectable compositions
pharmaceutically acceptable
Prior art date
Application number
BR0000011-6A
Other languages
Portuguese (pt)
Inventor
Nancy Jane Harper
Gautam Ramchandra Ranade
Qi Hong
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0000011A publication Critical patent/BR0000011A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Patente de Invenção: <B>"COMPOSIçõES INJETáVEIS DE ALATROFLOXACINA PRé-MISTURADAS"<D>. A presente invenção refere-se a composições farmacêuticas pré-misturadas (prontas para uso) para administração intravenosa contendo uma solução aquosa de alatrofloxacina ou um sal farmaceuticamente aceitável da mesma e agentes de tonicidade farmaceuticamente aceitáveis. A presente invenção refere-se também a métodos de utilização de tais composições para tratar ou prevenir uma variedade de infecções bacterianas.Invention Patent: <B> "PRE-MIXED ALATROFLOXACIN INJECTIBLE COMPOSITIONS" <D>. The present invention relates to premixed (ready-to-use) pharmaceutical compositions for intravenous administration containing an aqueous solution of alatrofloxacin or a pharmaceutically acceptable salt thereof and pharmaceutically acceptable tonicity agents. The present invention also relates to methods of using such compositions to treat or prevent a variety of bacterial infections.

BR0000011-6A 1999-01-28 2000-01-04 Injectable compositions of pre-mixed alatrofloxacin BR0000011A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11767899P 1999-01-28 1999-01-28

Publications (1)

Publication Number Publication Date
BR0000011A true BR0000011A (en) 2001-08-21

Family

ID=22374222

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0000011-6A BR0000011A (en) 1999-01-28 2000-01-04 Injectable compositions of pre-mixed alatrofloxacin

Country Status (4)

Country Link
JP (1) JP2000219628A (en)
BR (1) BR0000011A (en)
CA (1) CA2293008A1 (en)
MX (1) MXPA00000973A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2368553T1 (en) 2003-04-08 2015-05-29 Progenics Pharmaceuticals, Inc. Pharmaceutical formulations containing methylnaltrexone
TW200900066A (en) * 2007-03-22 2009-01-01 Daiichi Sankyo Co Ltd Quinolone medical composition containing alcohols
CN102512364A (en) * 2011-12-30 2012-06-27 天津市嵩锐医药科技有限公司 Alatrofloxacin mesylate medicine composition for injection
WO2016035846A1 (en) 2014-09-04 2016-03-10 塩野義製薬株式会社 Pharmaceutical preparation comprising cephalosporin having catechol groups

Also Published As

Publication number Publication date
CA2293008A1 (en) 2000-07-28
MXPA00000973A (en) 2008-11-20
JP2000219628A (en) 2000-08-08

Similar Documents

Publication Publication Date Title
YU13695A (en) Application of 2-phenyl-3-aroylbenzothiophene and pharmaceutical formulations thereof
DE69529670D1 (en) OXAZOLIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
RS114004A (en) Modified 2&#39; and 3&#39;-nucleoside produgs for treating flaviridae infections
HUP0001170A2 (en) Pharmaceutical compositions containing benzimidazole-2-carbamate derivatives as active ingredients for the treatment of viral infections and cancer
TR200003478T2 (en) Isothiazole derivatives useful as anticancer agents
BRPI9810519A (en) 4&#39;&#39;-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives and pharmaceutical composition comprising the same.
LU91254I2 (en) Daptomycin and its pharmaceutically acceptable derivatives (cubicinr)
ATE387430T1 (en) COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE INGREDIENTS
BRPI0008614B8 (en) tricyclic poly(adp-ribose) polymerase inhibitor compound, and pharmaceutical composition containing such compound.
BR9810097A (en) Derivatives of c-4-substituted macrolides
BR0000003A (en) Azalides and methods of preparing them
DK0585155T3 (en) Trifluoromethylketone peptide derivatives with HLE inhibitory activity, their preparation and pharmaceutical preparations
EA199800938A1 (en) COMPOSITIONS CONTAINING ANTIGREBING AGENT AND ACETATE BUFFER
BR9408305A (en) Compound pharmaceutical composition processes for the treatment of AIDS and HIV infection for the preparation of HIV infection and for inhibition of HIV protease and combination of compounds
BR0110382A (en) Use of azalide antibiotic compositions for the treatment or prevention of a bacterial or protozoal infection in mammals
KR910004191A (en) Renal disease treatment
BR0000011A (en) Injectable compositions of pre-mixed alatrofloxacin
GEP20032970B (en) Pharmaceutical Compositions of Tizoxanide and Nitazoxanide
TR200103144T2 (en) New compounds
BR0112338A (en) Compound, pharmaceutical composition, and use of a compound
BR9807444A (en) Antimicrobial product
BR0011845A (en) Pharmaceutical complex
DE69318715D1 (en) PHARMACOLOGICALLY ACTIVE ALPHA- (TERTIARY-AMINOETHYL) -PHENYLMETHANOL DERIVATIVES
KR950008502A (en) 3-or 4-clicosyloxybenzopyran derivatives and allergic agents containing the same as the active ingredient
BR9915161A (en) Vancoresmycin, process for its production and its use as a drug

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 3A ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1838 DE 28/03/2006.